Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Researchers develop promising targeted strategy to treat chemo-resistant blood cancer

Researchers develop promising targeted strategy to treat chemo-resistant blood cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

New blood test for pediatric brain tumor patients offers safer approach than surgical biopsies

New blood test for pediatric brain tumor patients offers safer approach than surgical biopsies

Study suggests new approach to treat life-threatening blood disorder in children

Study suggests new approach to treat life-threatening blood disorder in children

Eight promising biomedical research projects receive ASH Bridge Grants

Eight promising biomedical research projects receive ASH Bridge Grants

Study identifies tumor cell population responsible for resistance to therapy and cancer relapse

Study identifies tumor cell population responsible for resistance to therapy and cancer relapse

'Supercharged' immune cells could help fight cancer

'Supercharged' immune cells could help fight cancer

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

MD Anderson and Cyclacel announce strategic alliance to evaluate novel drugs for hematological malignancies

MD Anderson and Cyclacel announce strategic alliance to evaluate novel drugs for hematological malignancies

Could 'natural adaptive therapies' be a better way to keep cancer under control?

Could 'natural adaptive therapies' be a better way to keep cancer under control?

New way of using natural killer cells makes immunotherapy viable to more patients

New way of using natural killer cells makes immunotherapy viable to more patients

Study sheds light on transport of enzyme involved in stem cell differentiation to DNA

Study sheds light on transport of enzyme involved in stem cell differentiation to DNA

Researchers caution that expediting HLH treatment may miss underlying cancers

Researchers caution that expediting HLH treatment may miss underlying cancers

Why patients with ALL relapse after CAR-T cell therapy

Why patients with ALL relapse after CAR-T cell therapy

Why patients with ALL relapse after CAR-T cell therapy

Why patients with ALL relapse after CAR-T cell therapy

New analysis confirms value of minimal residual disease as prognostic indicator in multiple myeloma

New analysis confirms value of minimal residual disease as prognostic indicator in multiple myeloma

FDA permits marketing of ClonoSEQ assay to detect minimal residual disease in blood cancer patients

FDA permits marketing of ClonoSEQ assay to detect minimal residual disease in blood cancer patients

Cancer undercuts ability of normal cells to consume glucose, finds study

Cancer undercuts ability of normal cells to consume glucose, finds study

Researchers design new combination therapy for reducing NSCLC cell growth

Researchers design new combination therapy for reducing NSCLC cell growth

Loyola announces plans to produce CAR-T cells for treating cancer

Loyola announces plans to produce CAR-T cells for treating cancer